Germany secured 50 mln vaccine doses from CureVac, BioNTech on top of EU supplies - (National Post via NewsPoints Desk)

  • According to a health ministry document and an official, the German government struck two preliminary deals with BioNTech and CureVac last summer to secure 50 million doses of their COVID-19 vaccines, as reported in the National Post on Friday.

  • The deals, which were not announced when they were signed, are deemed controversial because EU governments had agreed not to negotiate bilateral supply agreements with vaccine makers.

  • The ministry official said Germany signed a memorandum of understanding with CureVac on August 31 for the supply of 20 million doses of its vaccine under development.

  • The official said the country also signed a similar preliminary deal on September 8 with BioNTech for 30 million doses of the vaccine it co-developed with Pfizer.

  • Deliveries to Germany under both deals would start only after EU countries were supplied under EU deals, according to the official.

  • This included an EU contract announced earlier on Friday for 300 million additional doses, a spokesman for the health ministry added.

To read more NewsPoints articles, click here.